Prion-Disease Trials on the Horizon?

The discoverer of prions, the pathogens implicated in the fatal, brain-wasting mad cow disease (bovine spongiform encephalopathy, BSE) and Creutzfeldt-Jakob disease (CJD), announced recently that a therapy against them would likely be available within the next five to 10 years, but he added that scientists are still mystified by exactly what circumstances cause the pathogens to produce infections in animals and humans. "We thought that the number of cases of the disease would increase two to th

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

"We thought that the number of cases of the disease would increase two to three times, but the number of cases in 2001 was similar to the number in 2000," Stanley B. Prusiner, 1997 Nobel Prize winner, told a crowded room of scientists at the University of Pennsylvania on Feb. 13. Prion diseases are difficult to predict, he said, because they involve so many variables. For example, it is still unknown why the new variant form of CJD disease, caused by BSE, is confined to young people while inherited CJD, also known as sporadic CJD, afflicts only the aged, he said.

All the same, after almost 20 years researching prions, "I think we now know enough about these diseases to really mount a program that hopefully will give us a therapy," said the neurologist and biochemist who directs the University of California, San Francisco, Institute for Neurodegenerative Diseases. The most ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Jennifer Fisher Wilson

    This person does not yet have a bio.

Published In

Share
Image of a woman in a microbiology lab whose hair is caught on fire from a Bunsen burner.
April 1, 2025, Issue 1

Bunsen Burners and Bad Hair Days

Lab safety rules dictate that one must tie back long hair. Rosemarie Hansen learned the hard way when an open flame turned her locks into a lesson.

View this Issue
Faster Fluid Measurements for Formulation Development

Meet Honeybun and Breeze Through Viscometry in Formulation Development

Unchained Labs
Conceptual image of biochemical laboratory sample preparation showing glassware and chemical formulas in the foreground and a scientist holding a pipette in the background.

Taking the Guesswork Out of Quality Control Standards

sartorius logo
An illustration of PFAS bubbles in front of a blue sky with clouds.

PFAS: The Forever Chemicals

sartorius logo
Unlocking the Unattainable in Gene Construction

Unlocking the Unattainable in Gene Construction

dna-script-primarylogo-digital

Products

Metrion Biosciences Logo

Metrion Biosciences launches NaV1.9 high-throughput screening assay to strengthen screening portfolio and advance research on new medicines for pain

Biotium Logo

Biotium Unveils New Assay Kit with Exceptional RNase Detection Sensitivity

Atelerix

Atelerix signs exclusive agreement with MineBio to establish distribution channel for non-cryogenic cell preservation solutions in China

Green Cooling

Thermo Scientific™ Centrifuges with GreenCool Technology

Thermo Fisher Logo